Analysis of the molecular expression profile of non small cell lung carcinoma associated to chronic obstructive pulmonary disease.

Keywords

COPD, Medicine, Lung cancer, Internal medicine, Univariate analysis

References

• Prognosis in chronic obstructive pulmonary disease.John E. Hodgkin — 1990
• Molecular genetics of lung cancer.Michael J. Birrer, John D. Minna — 1988
• [The incidence, trend and survival in lung cancer by histological type in Gipuzkoa )1983-1992)].Ricardo Rezola Solaun, J M Sanzo Ollakarizketa — 1999
• EGFR tyrosine kinase domain mutations are detected in histologically normal respiratory epithelium in lung cancer patients.Ximing Tang, Hisayuki Shigematsu, B. Nebiyou Bekele — 2005
• Cigarette smoking is strongly associated with mutation of the K‐ras gene in patients with primary adenocarcinoma of the lungSteven A. Ahrendt, P. Decker, Enas Alawi — 2001
• Trends in incidence and prognosis of the histological subtypes of lung cancer in North America, Australia, New Zealand and Europe.M Janssen-Heijnen, J.W.W. Coebergh — 2001
• Assessment of operative risk in patients undergoing lung resection. Importance of predicted pulmonary function.David J. Kearney, T. H. LEE, John J. Reilly — 1994
• Non‐small cell lung carcinomas with neuroendocrine features. A light microscopic, immunohistochemical and ultrastructural study of 11 casesW. J. Mooi, A Dewar, D.R. Springall — 1988
• Trends in Cancer Incidence and MortalityDavid Machin — 1995
• Increased socioeconomic differences in mortality in eight Spanish provinces.Enrique Regidor, Juan Luis Gutiérrez-Fisac, Carmen B. Rodriguez — 1995
• Progress in understanding the molecular pathogenesis of human lung cancer.Yoshitaka Sekido, Kwun M. Fong, John D. Minna — 1998
• Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancersGerd P. Pfeifer, Mikhail F. Denissenko, Magali Olivier — 2002
• Genetic analysis of lung tumours of non-smoking subjects: p53 gene mutations are constantly associated with loss of heterozygosity at the FHIT locus.Antonella Marchetti, Silvia Pellegrini, Gabriella Sozzi — 1998
• Assessment of operative risk in patients undergoing lung resection. Importance of predicted pulmonary function.Paul D. Scanlon — 1994
• Lung cancer and cigarette smoking in women: A case‐control study in barcelona (Spain)Antonio Agudo, Agustí Barnadas, Cinta Pallarés — 1994
• Estimates of global mortality attributable to smoking in 2000.Majid Ezzati, Alan D López — 2003
• Long-term survival after non-small cell lung cancer surgery: development and validation of a prognostic model with a preoperative and postoperative mode.Özcan Birim, A. Pieter Kappetein, Marco Waleboer — 2006
• Higher risk of lung cancer in chronic obstructive pulmonary disease. A prospective, matched, controlled study.David M. Skillrud, KENNETH P. OFFORD, R. DREW MILLER — 1986
• Are COPD and lung cancer two manifestations of the same disease?Thomas L. Petty — 2005
• Prognostic models of thirty-day mortality and morbidity after major pulmonary resection.David H. Harpole, Malcolm M. DeCamp, Jennifer Daley — 1999

Cited by

No citing papers recorded for this paper.

Related papers

• Integrative analysis of genomic sequencing data reveals higher prevalence of LRP1B mutations in lung adenocarcinoma patients with COPDDakai Xiao, Fuqiang Li, Hui Pan — 2017
• Identification of Survival-Associated Gene Signature in Lung Cancer Coexisting With COPDTi‐wei Miao, Long-yi Du, Wei Xiao — 2021
• A Panel of Sputum-Based Genomic Marker for Early Detection of Lung CancerFeng Jiang, Nevins W. Todd, Ruiyun Li — 2010
• A five-gene signature and clinical outcome in non-small-cell lung cancer.Hsuan‐Yu Chen, Sung‐Liang Yu, Chun‐Houh Chen — 2007
• The Prognostic Value of Phosphorylated AKT Expression in Non-Small Cell Lung Cancer: A Meta-AnalysisZhi-Xin Qiu, Kui Zhang, Xue-Song Qiu — 2013
• The diagnostic role of microRNA 21 in patients with nonsmall cell lung cancer: An exploratory studyPankajKumar Garg, Shreyash Rai, Shuchi Bhatt — 2020
• Age- and sex-specific genomic profiles in non-small cell lung cancer.William Mostertz — 2010
• FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinomaNaoyuki Okabe, Junji Ezaki, Takumi Yamaura — 2015
• Immunohistochemistry evaluation of biomarker expression in non-small cell lung cancer (Pharmacogenoscan study).Anne‐Claire Toffart, Jean‐François Timsit, S. Couraud — 2014
• Discovery and validation of extracellular vesicle‐associated miRNAs as noninvasive detection biomarkers for early‐stage non‐small‐cell lung cancerYujie Zhong, Xiaoyu Ding, Yuying Bian — 2020